Viridian Therapeutics, Inc. (VRDN) Tops Q1 EPS by 11c

Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q1 EPS of ($0.87), $0.11 better than the analyst estimate of ($0.98). Revenue for the quarter came in at $70 thousand versus the consensus estimate of $52.09 thousand.

For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• General Dynamics wins $249m in US military contracts
• EU proposes to curb Airbnb and short-term rentals amid housing shortage